TJU | JMC logo
The Bottom Line: Achieving Diabetes Treatment Goals
VOLUME 1 ISSUE 4
CASE JJ
JJ is a 53-year-old man with type 2 diabetes diagnosed 15 years ago, who returns to the office for a scheduled follow-up visit.
CHIEF COMPLAINT
CURRENT MEDICATIONS
FAMILY AND SOCIAL HISTORY
REVIEW OF SYSTEMS
EXAMINATION
PROBLEMS
NAVIGATION

Go BackContinue

Q: What is the significance of microalbuminuria in the natural history of diabetic nephropathy?

A: When measured under the right conditions (see above) and confirmed by a second measurement, a spot urine microalbumin level of >30 to 300 µg/mg creatinine indicates incipient nephropathy. Levels >300 µg microalbumin/mg creatinine are consistent with gross proteinuria; precise quantitation of proteinuria in a 24-hour urine collection is indicated for proper management of such patients.

Sequential phases in the natural history of diabetic nephropathy involve initial glomerular hyperfiltration, followed by microalbuminuria, persistent gross proteinuria (>300 µg/mg creatinine or >300 mg/24 h), nephrotic syndrome, and end-stage renal failure. Histologic lesions consistent with diabetic kidney disease are seen in ~100% of patients with type 1 diabetes with proteinuria and ~85% of patients with type 2 diabetes with proteinuria and concomitant retinopathy. Microalbuminuria, a potentially reversible stage of incipient nephropathy, precedes gross proteinuria by several years in both type 1 and type 2 diabetes. After gross proteinuria has developed, progression to nephrotic syndrome, impaired glomerular filtration, and end-stage renal failure occurs over several years at a variable, but inexorable, pace. The mean duration from diagnosis of type I diabetes to development of overt proteinuria is 17 years, and the time from the occurrence of proteinuria to end-stage renal failure averages 5 years. The natural history of nephropathy is less well understood in type 2 than in type 1 diabetes because of the uncertainty of the duration of diabetes and presence of confounding risk factors such as hypertension and dyslipidemia.2-4


Go BackContinue

Questions? Contact 1-888-JEFF-CME (533-3263) or
http://jeffline.jefferson.edu/jeffcme


The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.

Return to Thomas Jefferson University Home Page